Idraparinux risky for embolism prevention in AF patients

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1597, 2007-01, pp. : 8-8

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Idraparinux effective, but risky, for venous thromboembolism

By  

Inpharma, Vol. 1, Iss. 1606, 2007-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Warfarin superior for stroke prevention in patients with AF

By  

Inpharma, Vol. 1, Iss. 1601, 2007-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Ximelagatran simplifies stroke prevention for patients with AF

By  

Inpharma, Vol. 1, Iss. 1419, 2004-01 ,pp. : 7-8

Adis International

Access to resources Recommend Favorite

Spotlight on Dabigatran Etexilate in the Prevention of Stroke and Systemic Embolism in Patients with Atrial Fibrillation†

By Garnock-Jones Karly P.  

Drugs & Aging, Vol. 28, Iss. 5, 2011-05 ,pp. : 415-419

Adis International

Access to resources Recommend Favorite

Dabigatran Etexilate: A Review of its Use in the Prevention of Stroke and Systemic Embolism in Patients with Atrial Fibrillation

By Garnock-Jones Karly P.  

American Journal of Cardiovascular Drugs, Vol. 11, Iss. 1, 2011-02 ,pp. : 57-72

Adis International

Access to resources Recommend Favorite